SUPPLIER OF PROTON THERAPY THAT FITS YOUR FACILITY

P-Cure delivers the most compact 360^o gantry-less adaptive proton therapy system that fits existing infrastructure of any radiation oncology department

Request A Demo

Clinical Efficacy

P-Cure aims to shift treatment efficacy to a new, unprecedented level – a quantum leap forward in reducing the magnitude of internal organ motion and markedly improving imaging resolution.

Clinical Safety

P-Cure’s treatment solution is expected to yield improved dose distribution, thereby exposing healthy tissues and organs to significantly less radiation.

Technology

With the FDA-cleared Gantry-Less Proton Therapy Solution, patients can be treated in seated or supine positions. It is complemented by synchrotron-generated pencil beam scanning to ensure a continuous and precise treatment plan is delivered.

Compact

Our solution, comparable in size to single floor linac rooms, is 5 times smaller than a gantry room, and requires 50 percent less shielding.

Cost Efficient

The P-Cure solution can reduce the capital costs of a proton center by 50 percent, providing wider availability of proton therapy and faster ROI.

Patient Position

Greater comfort, less organ movement, and a potential reduction in collateral radiation to sensitive organs.

Industry opinion leaders say

Hanne M. Kooy, Ph.D.

Associate Professor of Radiation Oncology, Massachusetts General Hospital

“Adaptive therapy approach combined with a proton beam scanning is a quantum leap in our ability to cure cancer patients with radiation.”

Zelig A. Tochner, MD

Former Emeritus Professor of Radiation Oncology, University of Pennsylvania

“P-Cure’s gantry-less system can significantly reduce the cost of the initial investment required to establish proton therapy services.”

William F. Hartsell, MD

Radiation Oncologist & Medical Director, Chicago Proton Center Radiation Oncology

"We expect that imaging lung cancer patients in the upright position will allow us to more precisely target the tumor when we treat it with proton therapy.”